KDR and gastrointestinal stromal tumor: First line therapy for metastatic renal cell carcinoma and gastrointestinal stromal tumors includes sunitinib which is a protein tyrosine kinase inhibitor targeting VEGF-R, c-kit, and PDGF-R.